Researchers find cholesterol-lowering drugs have no effect on kidney function
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Jul-2025 20:11 ET (16-Jul-2025 00:11 GMT/UTC)
A brain rhythm working in tandem with the body’s natural sleep-wake cycle may explain why bipolar patients alternate between mania and depression, according to new research.
The McGill University-led study published in Science Advances marks a breakthrough in understanding what drives shifts between the two states, something that, according to lead author Kai-Florian Storch, is considered the “holy grail” of bipolar-disorder research.
If you’re like many Americans, you probably didn’t take all your vacation time this year. Even if you did, it’s highly likely you didn’t fully unplug while off the clock. But you might want to change that if you want to improve your health and well-being, according to a new review article from the University of Georgia.
Nudging with carbon footprint labeling and product categorization motivates online shoppers to select plant-based foods, according to new research published by agricultural economists at Purdue University and the University of Kentucky.
“A lot of research has been done on point-of-purchase nudges, but that has been done in a physical setting. In this study, we look at that in the growing domain of online grocery shopping,” said Bhagyashree Katare, associate professor of agricultural economics at Purdue University. “It provides actionable evidence that small interventions can increase the selection of plant-based products or healthy products.”
University of Missouri researchers and collaborators have developed a new chemical tool that could help lower the cost of prescription medications. The tool, called AshPhos, is a ligand, or molecule, that makes it easier to create special carbon-nitrogen bonds. These bonds are the backbone of more than half of all medicines on the market today.
A new study by researchers at Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Tufts Medical Center and UMass Memorial Medical Center has found that drug screening practices may be inconsistent with potential downstream effects in reporting to the RMV.
The Mount Sinai Hospital has performed New York City’s first procedure using the HYDROS™ Robotic System, a cutting-edge technology designed to treat benign prostatic hyperplasia (BPH), or an enlarged prostate. The minimally invasive procedure offers new hope for patients experiencing the symptoms of BPH, including frequent urination, incomplete bladder emptying, and nighttime urgency. Urologists at the hospital recently performed the health system’s first three procedures, with all patients responding well to the treatment and being discharged the following day.